ACM Research, Inc. (NASDAQ:ACMR – Free Report) – Stock analysts at Roth Capital lifted their Q4 2024 EPS estimates for ACM Research in a note issued to investors on Tuesday, January 14th. Roth Capital analyst S. Desilva now forecasts that the specialty retailer will earn $0.06 per share for the quarter, up from their prior estimate of $0.01. The consensus estimate for ACM Research’s current full-year earnings is $1.12 per share. Roth Capital also issued estimates for ACM Research’s Q1 2025 earnings at ($0.04) EPS, Q2 2025 earnings at $0.14 EPS, Q3 2025 earnings at $0.37 EPS and Q4 2025 earnings at $0.51 EPS.
ACMR has been the subject of several other research reports. Craig Hallum downgraded shares of ACM Research from a “buy” rating to a “hold” rating and reduced their price target for the company from $30.00 to $18.00 in a research report on Thursday, December 5th. Needham & Company LLC cut ACM Research from a “buy” rating to a “hold” rating and set a $25.00 price target for the company. in a research note on Wednesday, December 4th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $30.00.
ACM Research Stock Down 1.2 %
NASDAQ:ACMR opened at $17.68 on Friday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.34 and a current ratio of 2.37. The firm has a market cap of $1.02 billion, a P/E ratio of 13.39 and a beta of 1.48. ACM Research has a fifty-two week low of $13.87 and a fifty-two week high of $34.40. The firm has a 50-day simple moving average of $16.52 and a two-hundred day simple moving average of $18.41.
ACM Research (NASDAQ:ACMR – Get Free Report) last released its earnings results on Thursday, November 7th. The specialty retailer reported $0.63 EPS for the quarter, topping the consensus estimate of $0.28 by $0.35. The business had revenue of $204.00 million for the quarter, compared to the consensus estimate of $191.18 million. ACM Research had a return on equity of 9.07% and a net margin of 12.38%. The company’s revenue for the quarter was up 21.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.41 earnings per share.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC lifted its position in ACM Research by 2.3% during the third quarter. Geode Capital Management LLC now owns 1,180,741 shares of the specialty retailer’s stock valued at $23,973,000 after purchasing an additional 26,620 shares in the last quarter. Millennium Management LLC grew its stake in ACM Research by 283.9% during the second quarter. Millennium Management LLC now owns 924,104 shares of the specialty retailer’s stock valued at $21,310,000 after acquiring an additional 683,361 shares in the last quarter. Portolan Capital Management LLC increased its holdings in shares of ACM Research by 7.7% in the third quarter. Portolan Capital Management LLC now owns 921,451 shares of the specialty retailer’s stock worth $18,705,000 after purchasing an additional 65,616 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of ACM Research by 3.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 405,858 shares of the specialty retailer’s stock worth $8,239,000 after buying an additional 13,879 shares in the last quarter. Finally, Citigroup Inc. grew its holdings in ACM Research by 8.7% during the 3rd quarter. Citigroup Inc. now owns 340,207 shares of the specialty retailer’s stock valued at $6,906,000 after buying an additional 27,178 shares in the last quarter. 66.75% of the stock is currently owned by institutional investors.
Insider Activity at ACM Research
In other ACM Research news, Director Haiping Dun sold 15,000 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $19.12, for a total value of $286,800.00. Following the transaction, the director now owns 774,148 shares of the company’s stock, valued at approximately $14,801,709.76. This represents a 1.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider David H. Wang sold 56,250 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $17.89, for a total value of $1,006,312.50. Following the sale, the insider now owns 654,256 shares of the company’s stock, valued at approximately $11,704,639.84. This represents a 7.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 127,500 shares of company stock worth $2,366,363 over the last quarter. Company insiders own 31.24% of the company’s stock.
About ACM Research
ACM Research, Inc, together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating.
Featured Articles
- Five stocks we like better than ACM Research
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Bank Stocks Are on Fire; Here’s Where the Action Is Smoking Hot
- Dividend Payout Ratio Calculator
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How to Use the MarketBeat Stock Screener
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
Receive News & Ratings for ACM Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACM Research and related companies with MarketBeat.com's FREE daily email newsletter.